Comparison of the in vitro estrogenic activities of compounds from hops (Humulus lupulus) and red clover (Trifolium pratense)

Journal of Agricultural and Food Chemistry

Volumn 53, Issue 16, 2005, Pages 6246-6253

  Overk, Cassia R ^a   Yao, Ping ^a   Chadwick, Lucas R ^a   Nikolic, Dejan ^a   Sun, Yongkai ^a   Cuendet, Muriel A ^a   Deng, Yunfan ^a   Hedayat, A S ^a   Pauli, Guido F ^a   Farnsworth, Norman R ^a   Van Breemen, Richard B ^a   Bolton, Judy L ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Alkaline phosphatase; Estrogen receptor; Hops; Humulus lupulus; Menopause; Progesterone receptor; Red clover; Trifolium pratense

Indexed keywords

ALKALINE PHOSPHATASE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; LUCIFERASE; PHYTOESTROGEN; PROGESTERONE RECEPTOR;

ARTICLE; BIOSYNTHESIS; CHEMISTRY; CLOVER; DNA RESPONSIVE ELEMENT; DRUG EFFECT; GENE EXPRESSION; GENETIC TRANSFECTION; GENETICS; HUMAN; HUMULUS; ISOLATION AND PURIFICATION; METABOLISM; TUMOR CELL LINE;

ALKALINE PHOSPHATASE; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; GENE EXPRESSION; HUMANS; HUMULUS; LUCIFERASES; PHYTOESTROGENS; RECEPTORS, PROGESTERONE; RESPONSE ELEMENTS; TRANSFECTION; TRIFOLIUM;

HUMULUS LUPULUS; MINK CELL FOCUS-FORMING VIRUS; TRIFOLIUM PRATENSE;

EID: 23844475750     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf050448p     Document Type: Article

References (47)

1. Shaver, J. L.; Giblin, E.; Paulsen, V. Sleep quality subtypes in midlife women. Sleep 1991, 14, 18-23.
2. Barlow, D. H. Who understands the menopause? Br. J. Obstet. Gynaecol. 1997, 104, 879-880.
3. Kronenberg, F. Hot flashes: Phenomenology, quality of life, and search for treatment options. Exp. Gerontol. 1994, 29, 319-336.
4. Genazzani, A. R.; Gambacciani, M. HRT in the third millennium. Maturitas 2001, 38 (Suppl. 1), S49-S55.
5. Murkies, A. L.; Wilcox, G.; Davis, S. R. Clinical review 92: Phytoestrogens. Clin. Endocrinol. Metab. 1998, 83, 297-303.
6. Setchell, K. D. Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr. 1998, 68, 1333S-1346S.
7. Setchell, K. D.; Cassidy, A. Dietary isoflavones: Biological effects and relevance to human health. J. Nutr. 1999, 129, 758S-767S.
8. Million women study collaborators breast cancer and hormone-replacement therapy: The million women study. Lancet 2003, 362, 419-427.
9. Fournier, A.; Berrino, F.; Riboli, E.; Avenel, V.; Clavel-Chapelon, F. Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int. J. Cancer 2005, 114, 448-454.
10. Shumaker, S. A.; Legault, C.; Thal, L.; Wallace, R. B.; Ockene, J. K.; Hendrix, S. L.; Jones, B. N., 3rd; Assaf, A. R.; Jackson, R. D.; Kotchen, J. M.; Wassertheil-Smoller, S.; Wactawski-Wende, J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: a randomized controlled trial. J. Am. Med. Assoc. 2003, 289, 2651-2662.
11. Wassertheil-Smoller, S.; Hendrix, S. L.; Limacher, M.; Heiss, G.; Kooperberg, C.; Baird, A.; Kotchen, T.; Curb, J. D.; Black, H.; Rossouw, J. E.; Aragaki, A.; Safford, M.; Stein, E.; Laowattana, S.; Mysiw, W. J. Effect of estrogen plus progestin on stroke in postmenopausal women: The Women's Health Initiative: a randomized trial. J. Am. Med. Assoc. 2003, 289, 2673-2684.
12. Rossouw, J. E.; Anderson, G. L.; Prentice, R. L.; LaCroix, A. Z.; Kooperberg, C.; Stefanick, M. L.; Jackson, R. D.; Beresford, S. A.; Howard, B. V.; Johnson, K. C.; Kotchen, J. M.; Ockene, J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. J. Am. Med. Assoc. 2002, 288, 321-333.
13. Piersen, C. E. Phytoestrogens in botanical dietary supplements: implications for cancer. Integr. Cancer Ther. 2003, 2, 120-138.
14. Stevens, J. F.; Miranda, C. L.; Buhler, D. R.; Deinzer, M. L. Chemistry and biology of hop flavonoids. J. Am. Soc. Brew. Chem. 1998, 56, 136-145.
15. Koch, W.; Heim, G. Estrogens in hops and beer. Munch. Med. Wochenschr. 1953, 95, 845.
16. Milligan, S. R.; Kalita, J. C.; Heyerick, A.; Rong, H.; De Cooman, L.; De Keukeleire, D. Identification of a potent phytoestrogen in hops (Humulus lupulus L.) and beer. J. Clin. Endocrinol. Metab. 1999, 84, 2249-2252.
17. Milligan, S. R.; Kalita, J. C.; Pocock, V.; Van De Kauter, V.; Stevens, J. F.; Deinzer, M. L.; Rong, H.; De Keukeleire, D. The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. J. Clin. Endocrinol. Metab. 2000, 85, 4912-4915.
18. Hänsel, R. V.; Schulz, J. Desmethylxanthohumol: Isolierung aus hopfen und cyclisierung zu flavanonen. Arch. Pharm. Weinheim 1988, 321, 37-40.
19. Chadwick, L. R.; Nikolic, D.; Burdette, J. F.; Overk, C. R.; Bolton, J. L.; van Breemen, R. B.; Froehlich, R.; Fong, H. H.; Farnsworth, N. R.; Pauli, G. F. Estrogens and congeners from spent hops (Humulus lupulus L.). J. Nat. Prod. 2004, 67, 2024-2032.
20. Zierau, O.; Hauswald, S.; Schwab, P.; Metz, P.; Vollmer, G. Two major metabolites of 8-prenylnaringenin are estrogenic in vitro. J. Steroid Biochem. Mol. Biol. 2004, 92, 107-110.
21. Zierau, O.; Gester, S.; Schwab, P.; Metz, P.; Kolba, S.; Wulf, M.; Vollmer, G. Estrogenic activity of the phytoestrogens naringenin, 6-(1,1-dimethylallyl)naringenin and 8-prenylnaringenin. Planta Med. 2002, 68 (5), 449-451.
22. Diel, P.; Thomae, R. B.; Caldarelli, A.; Zierau, O.; Kolba, S.; Schmidt, S.; Schwab, P.; Metz, P.; Vollmer, G. Regulation of gene expression by 8-prenylnaringenin in uterus and liver of Wistar rats. Planta Med. 2004, 70, 39-44.
23. Liu, J.; Burdette, J. E.; Xu, H.; Gu, C.; van Breemen, R. B.; Bhat, K. P.; Booth, N.; Constantinou, A. I.; Pezzuto, J. M.; Fong, H. H.; Farnsworth, N. R.; Bolton, J. L. Evaluation of estrogenic activity of plant extracts for the potential treatment of menopausal symptoms. J. Agric. Food Chem. 2001, 49, 2472-2479.
24. Liggins, J.; Bluck, L. J.; Coward, W. A.; Bingham, S. A. Extraction and quantification of daidzein and genistein in food. Anal. Biochem. 1998, 264, 1-7.
25. Piersen, C. E.; Booth, N. L.; Sun, Y.; Liang, W.; Burdette, J. E.; van Breemen, R. B.; Geller, S. E.; Gu, C.; Banuvar, S.; Shulman, L. P.; Bolton, J. L.; Farnsworth, N. R. Chemical and biological characterization and clinical evaluation of botanical dietary supplements: A phase I red clover extract as a model. Curr. Med. Chem. 2004, 11, 1361-1374.
26. Hu, M.; Krausz, K.; Chen, J.; Ge, X.; Li, J.; Gelboin, H. L.; Gonzalez, F. J. Identification of CYP1A2 as the main isoform for the phase I hydroxylated metabolism of genistein and a prodrug converting enzyme of methylated isoflavones. Drug Metab. Dispos. 2003, 31, 924-931.
27. Kronenberg, F.; Fugh-Berman, A. Complementary and alternative medicine for menopausal symptoms: A review of randomized, controlled trials. Ann. Intern. Med. 2002, 137, 805-813.
28. Sun, Y.; Gu, C.; Liu, X.; Liang, W.; Yao, P.; Bolton, J. L.; van Breemen, R. B. Ultrafiltration tandem mass spectrometry of estrogens for characterization of structure and affinity for human estrogen receptors. J. Am. Soc. Mass Spectrom. 2005, 16, 271-279.
29. Nikolic, D.; Li, Y.; Chadwick, L. R.; Pauli, G. F.; van Breemen, R. B. Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes. J. Mass Spectrom. 2005, 40, 289-299.
30. Zava, D. T.; Dollbaum, C. M.; Blen, M. Estrogen and progestin bioactivity of foods, herbs, and spices. Proc. Soc. Exp. Biol. Med. 1998, 217, 369-378.
31. Zava, D. T.; Blen, M.; Duwe, G. Estrogenic activity of natural and synthetic estrogens in human breast cancer cells in culture. Environ. Health Perspect. 1997, 105 (Suppl. 3), 637-645.
32. Booth, N. L.; Nikolic, D.; van Breemen, R. B.; Geller, S. E.; Banuvar, S.; Shulman, L. P.; Farnsworth, N. R. Confusion regarding anticoagulant coumarins in dietary supplements. Clin. Pharmacol. Ther. 2004, 76, 511-516.
33. Obourn, J. D.; Koszewski, N. J.; Notides, A. C. Hormone- and DNA-binding mechanisms of the recombinant human estrogen receptor. Biochemistry 1993, 32, 6229-6236.
34. Catherino, W. H.; Jordan, V. C. Increasing the number of tandem estrogen response elements increases the estrogenic activity of a tamoxifen analogue. Cancer Lett. 1995, 92, 39-47.
35. Mata-Greenwood, E.; Cuendet, M.; Sher, D.; Gustin, D.; Stock, W.; Pezzuto, J. M. Brusatol-mediated induction of leukemic cell differentiation and G(1) arrest is associated with down-regulation of c-myc. Leukemia 2002, 16, 2275-2284.
36. Pisha, E.; Pezzuto, J. M. Cell-based assay for the determination of estrogenic and anti-estrogenic activities. Methods Cell Sci. 1997, 19, 37-43.
37. Joung, K. E.; Kim, Y. W.; Sheen, Y. Y. Assessment of the estrogenicity of isoflavonoids, using MCF-7-ERE-Luc cells. Arch. Pharm. Res. 2003, 26, 756-762.
38. Holinka, C. F.; Hata, H.; Kuramoto, H.; Gurpide, E. Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells (Ishikawa line). Cancer Res. 1986, 46, 2771-2774.
39. Bramlett, K. S.; Burris, T. P. Target specificity of selective estrogen receptor modulators within human endometrial cancer cells. J. Steroid Biochem. Mol. Biol. 2003, 86, 27-34.
40. Mosselman, S.; Polman, J.; Dijkema, R. ER beta: Identification and characterization of a novel human estrogen receptor. FEBS Lett. 1996, 392, 49-53.
41. Kuiper, G. G.; Enmark, E.; Pelto-Huikko, M.; Nilsson, S.; Gustafsson, J. A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 5925-5930.
42. Milligan, S.; Kalita, J.; Pocock, V.; Heyerick, A.; De Cooman, L.; Rong, H.; De Keukeleire, D. Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin. Reproduction 2002, 123, 235-242.
43. Kuiper, G. G.; Lemmen, J. G.; Carlsson, B.; Corton, J. C.; Safe, S. H.; van der Saag, P. T.; van der Burg, B.; Gustafsson, J. A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139, 4252-4263.
44. Paech, K.; Webb, P.; Kuiper, G. G.; Nilsson, S.; Gustafsson, J.; Kushner, P. J.; Scanlan, T. S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997, 277, 1508-1510.
45. Schaefer, O.; Humpel, M.; Fritzemeier, K. H.; Bohlmann, R.; Schleuning, W. D. 8-Prenyl naringenin is a potent ERalpha selective phytoestrogen present in hops and beer. J. Steroid Biochem. Mol. Biol. 2003, 84, 359-360.
46. Peterson, T. G.; Ji, G. P.; Kirk, M.; Coward, L.; Falany, C. N.; Barnes, S. P. Department of Toxicology; Comprehensive Cancer Center Mass Spectrometry Shared Facility, U. o. A. a. B. U.S.A. Metabolism of the isoflavones genistein and biochanin A in human breast cancer cell lines. Am. J. Clin. Nutr. 1998, 68 (6) (Suppl.), 1505S-1511S.
47. Gerhauser, C.; Alt, A.; Heiss, E.; Gamal-Eldeen, A.; Klimo, K.; Knauft, J.; Neumann, I.; Scherf, H. R.; Frank, N.; Bartsch, H.; Becker, H. Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Mol. Cancer Ther. 2002, 1, 959-969.